Osmitol Syrup contains Lactitol (66.67% w/v) as its active ingredient and is primarily indicated for the treatment of constipation. Lactitol is a synthetic disaccharide derived from lactose, classified as an osmotic laxative. It functions by drawing water into the bowel lumen, thereby softening stools and promoting bowel movements without causing significant electrolyte imbalance. Osmitol Syrup is particularly useful in managing chronic constipation and facilitating bowel evacuation prior to diagnostic procedures or surgery. The onset of action typically occurs within 24 to 48 hours following oral administration. It is generally well tolerated, with minimal systemic absorption, reducing the risk of systemic side effects. Common adverse effects may include mild abdominal discomfort, bloating, or flatulence, which usually resolve with continued use. Osmitol Syrup should be used cautiously in patients with galactosemia, intestinal obstruction, or hypersensitivity to lactitol or any component of the formulation. Dosage should be individualized based on patient response and clinical condition. Adequate hydration is recommended during treatment to enhance efficacy and minimize potential side effects. As with all laxatives, prolonged use without medical supervision is not advised. Osmitol Syrup offers a safe and effective option for osmotic laxation in both adult and pediatric populations under appropriate medical guidance.